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Periodontal  diseases  are  a  group  of 
inflammatory diseases in which Gram-negative 
microorganisms  and  their  products  are  the 
principal  etiologic  agents.1  These  microorganisms, 
particularly  Porphyromonas  gingivalis  (P. 
gingivalis),  produce  endotoxins  in  the  form  of   
lipopolysaccharides (LPS) that are instrumental 
in generating a host-mediated tissue destructive 
immune response.2 Recent studies indicate that 
periodontal  disease  may  have  profound  effects 
on  systemic  health.  Subjects  with  periodontal 
disease may have a higher risk for cardiovascular 
disease when compared to subjects with a healthy 
periodontium.3  
The  biological  plausibility  for  a  periodontal 
infection-systemic  disease  link  can  be  briefly 
explained as follows. Periodontal infection causes 
bacteraemia  and  endotoxaemia  and  promotes 
systemic  inflammatory  and  immune  responses 
that may roles in systemic disease. Periodontal 
pathogens express specific virulence factors that 
can affect atherogenic events. Finally, periodontal 
pathogens have also been isolated from non-oral 
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tissues like atheromatous plaques.4
The  consequence  of  these  findings,  recent 
researches  have  been  focused  the  association 
of  periodontal  infection  and  systemic  disease, 
and in this relationship in the alterations of lipid 
metabolism have been revealed as a potentially 
inductive factor.5
A. PotEntIAL MEcHAnIsMs
In tHE AssocIAtIon bEtWEEn 
PErIodontAL dIsEAsE And 
HYPErLIPIdEMIA
1.  Infection and hyperlipidemia
Previously,  it  was  thought  that  serum  lipid 
alterations  were  related  to  the  underlying 
pathological  conditions  rather  than  the 
infectious process. However, recent studies have 
demonstrated that lipid metabolism may be altered 
by  chronic  local  and  acute  systemic  infections 
which are involved in the plasma concentrations 
of unregulated cytokines and hormones. The main 
features of this catabolic state are lipid oxidation 
and elevated free fatty acids, triglycerides and low 
density lipoprotein (LDL) cholesterol.6,7
Studies  in  humans  and  animals  have  shown 
a  number  of  cytokines  such  as  tumor  necrosis 
factor alpha (TNF-α) and interleukin-1 beta (IL-
1β) are produced in response to systemic Gram-
negative LPS exposure. It is believed that these 
cytokines  exert  effects  on  lipid  metabolism  by 
influencing production of other cytokines, altering 
hemodynamics/aminoacid  utilization  of  various 
tissues involved in lipid metabolism,8,9 or modifying 
the hypothalamic-pituitary-adrenal axis increasing 
plasma  concentrations  of  adrenocorticotropic 
hormone,  cortisol,  adrenaline,  noradrenaline, 
and  glucagon.10-12  Thus,  through  action  of 
TNF-α  and IL-1β, exposure to microorganisms/
endotoxin results in elevated levels of free fatty 
acids,  LDL  and  triglyceride.  These  elevations  in 
serum lipids are thought to arise from enhanced 
hepatic  lipogenesis,13,14 increased  adipose  tissue 
lipolysis/blood  flow,  increased  synthesis  or 
reduced  clearance  of  triglyceride,  and  reduced 
clearance of  LDL due to reductions in lipoprotein 
lipase  activity.15,16  Thus,  any  condition  producing 
elevations in serum TNF-α and IL-1β has potential 
to cause hyperlipidemia.
Lipids  may  interact  directly  with  the 
macrophage  cell  membrane,  interfering  with 
membrane-bound  receptors  and  enzyme 
systems, altering macrophage gene expression 
for  pro-inflammatory  cytokines  such  as  TNF-α 
and  IL-1β  and  essential  polypeptide  growth 
factors  such  as  platelet-derived  growth  factor 
(PDGF), transforming growth factor beta 1 (TGF-
β1) and basic fibroblast growth factor (bFGF).17,18 
Additionally,  serum  lipids,  whether  induced  by 
diabetes,  or  diet  increase  polymorphonuclear 
leukocyte (PMN) production of pro-inflammatory 
cytokines and inhibit macrophage production of 
essential  polypeptide  growth  factors  impairing 
the  wound  healing  process.  Furthermore, 
hyperlipidemia  may  be  more  important  than 
hyperglycemia  relative  to  the  hyper-responsive 
monosytic  phenotype19-21  and  development  of 
many diabetic complications.22
2. Interactions between bacterial 
lipopolysaccharides and serum lipoproteins
a. Bacterial infections, lipoprotein levels and 
lipoprotein metabolism
The  most  commonly  observed  infection-
induced  lipid  abnormalities  in  man  and 
experimental animals are increased triglyceride 
and very low density lipoprotein (VLDL) levels23 
and  decreased  high  density  lipoprotein  (HDL) 
cholesterol levels.24 A decrease in total and LDL 
cholesterol levels has also been reported during 
severe bacterial infections.25 However, in rodents 
and rabbits administration of LPS often leads to 
hypercholesterolemia.23 Hepatic and lipoprotein 
lipase  activity  levels  decreased  during  acute 
infections.26, 27
b. Abnormalities in lipid and lipoprotein 
levels: cytokine mediated effects
Tumor  necrosis  factor  (TNF)  induces  a 
rapid increase in serum triglyceride, VLDL and 
cholesterol levels. Although the mechanism by 
which  TNF  increases  serum  cholesterol  levels 
is unknown, the increase in hepatic cholesterol 
synthesis  may  be  due  to  an  increase  in  the 
activity of 3-hydroxy-3-methyl glutaryl coenzyme 
A (HMG-CoA) reductase.13
c. LPS-LDL interactions: effects on 
lipoprotein metabolism
Low  concentrations  of  LPS  inhibit  the 
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expression  of  scavenger  receptor  activity  on 
human monocyte-derived macrophages but had 
no effect on LDL receptor activity.28 Furthermore, 
when LPS is complexed with LDL the inhibitory 
effect  of  LPS  on  scavenger  receptor  activity  is 
markedly enhanced.29 Besides affecting scavenger 
and LDL receptors, LPS affects LDL metabolism 
by  precluding  its  hydrolysis.  Furthermore,  LPS 
binds to lipoproteins in direct proportion to their 
cholesterol content and that the LDL-LPS complex 
once taken by macrophages is not degraded.29
d.  LPS,  release  of  cytokines  and  LDL 
modification
Though  it  was  demonstrated  that  LPS 
causes  widespread  endotelial  damage,  in 
hypercholesterolemic status this damage seems 
to be more severe and persistent.30 In animals 
maintained  on  high  cholesterol  diets  for  the 
duration  of  the  experiment,  arteriosclerotic 
lesions may not be detectable until 3 months after 
administration of a single small dose of LPS, even 
so, LPS cause the initial endothelial damage, and 
hypercholesterolemia may interrupt the normal 
repair process.31
Another  possible  mechanism  by  which  LPS 
contributes to the development of atherosclerosis 
is  the  oxidative  modification  of  LDL  induced 
during macrophage activation. Several possible 
pathogenic roles with marked importance in the 
development of atherosclerosis may be attributed 
to oxidized LDL (ox-LDL). First, ox-LDL is taken up 
by macrophage scavenger receptors32,33 leading 
to the transformation of macrophages into foam 
cells, the hallmark of the atherosclerotic process. 
Second, ox-LDL is cytotoxic for endothelial cells34 
and is a potent chemo-attractant for circulating 
human monocytes.33
3. Lipoprotein-associated inflammatory 
proteins: mediators of cardiovascular disease
Plasma  lipoproteins  are  largely  involved  in 
the  transport  of  acute  phase  reactant  proteins 
such as C-reactive protein (CRP), serum amyloid 
A and secretory phospholipase A2 which greatly 
increases the risk of atherosclerosis.35
The  acute  phase  reactions,  associated  with 
injury, inflammation, or sepsis, markedly affect 
the  concentration  and  composition  of  plasma 
lipids  and  lipoproteins.  Hepatic  production  of 
triglycerides and LDL formation are increased, 
but  do  not  necessarily  result  in  high  plasma 
triglyceride  levels.  In  contrast,  all  conditions 
lower  plasma  cholesterol  by  decreasing  its 
content  in  both  low-density  and  high-density 
lipoproteins. In addition, substantial changes in 
protein and lipid composition of lipoproteins are 
observed that may redefine the function of these 
particles, but also increase their atherogenic and 
inflammatory properties.36 
4. Modulatory effects of dietary lipids on 
immune system functions
The  immune  response  of  both  humans  and 
animals may be influenced by several essential 
nutrients,  which  modify  the  immune  system 
functions. Dietary lipids or free fatty acids may 
be  modulate  the  immune  system  through  a 
great  number  of  mechanisms  that  include 
reduction of lymphocyte proliferation, reduction 
of  cytokine  synthesis,  increase  of  phagocytic 
activity,modification  of  natural  killer  (NK)  cell 
activity  and  so  on.  This  modulation  may  be 
associated with changes in the cell membrane 
due to dietary fatty acid manipulation. Fatty acids 
may be incorporated into the plasma membrane 
after  dietary  lipid  administration,  so  that  the 
composition  of  lipids  in  this  cellular  structure 
will  reflect  the  composition  of  dietary  lipids.37 
Because of this incorporation, the phospholipid 
profiles  associated  with  plasma  membrane 
of  lymphocytes,  monocytes/macrophages  or 
polymorphonuclear  cells  may  be  altered  by 
dietary lipids.38,39
Diets  including  polyunsaturated  fatty  acids, 
such  as  eicosapentaenoic  or  docosahexaenoic 
acids,  suppress  the  mitogenic  response  of 
lymphocytes to a greater extent than diets rich in 
saturated fatty acids.40
Fatty acids may regulate cytokine production 
and  in fact cytokine  modulation by fatty acids 
seems  to  be  responsible  for  the  reduction  of 
lymphocyte  proliferation  in  both  animals  and 
humans.  Cytokines  such  as  IL-1  and  TNF  are 
important  mediators  of  inflammation  and 
dietary  fatty  acids  have  been  demonstrated 
to  be  substances  capable  of  reducing  the 
pro-inflammatory  response  induced  by  IL-1 
and  TNF.41-43  The  mechanisms  involved  in  the 
modification of cytokine synthesis remain unclear 
as yet, but a possible explanation could be found 
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in the regulation at the transcriptional level, that 
is,  reduction  of  cytokine  mRNA  production  by 
polyunsaturated fatty acids.44 Dietary fatty acids 
may  also  be  able  to  modulate  activity  of    NK 
cells  participating  in  protection  against  virus, 
intracellular  bacteria  or  tumoral  cells.  Diets 
containing fish oil or olive oil produce the greatest 
percentage  of    NK  cell  activity  inhibition  in 
comparison with diets rich in saturated fatty acids 
or n-6 polyunsaturated fatty acids.45, 46 However, 
there are several reports are found, eicosanoids 
such as prostaglandins, leukotrienes or lipoxins 
may play important role in this mechanism.47-49 
It has been reported that unsaturated fatty acids 
increase  phagocytosis  which  is  an  important 
mechanism in many cells for the elimination of 
microorganisms or foreign particles.42,50
Mechanisms involved in fatty acid modulation 
are  membrane  fluidity,  production  of  lipid 
peroxides,  eicosanoid  synthesis  and  influence 
on  gene  regulation.  As  a  result  of  changes  in 
the  phospholipids  fatty  acid  composition  due 
to dietary lipid manipulation, the fluidity of the 
cell  membrane  may  change.  Fatty  acids  have 
inhibitory  effects  on  cellular  proliferation  due 
to  lipid  peroxidation  which  are  toxic  to  cells. 
Dietary fats have an important role in decreasing 
antioxidant enzyme mRNA levels and enhancing 
free radical-induced tissue damage. Fatty acids 
undergo enzymatic degradation to yield eicosanoid 
family (prostaglandins, leukotrienes or lipoxins) 
participating in inflammatory processes and are 
also related to immunomodulatory effects, which 
act as lipid mediators.51
b. PErIodontItIs And
HYPErLIPIdEMIA
The  alterations  in  immune  cell  phenotype 
due  to  serum  lipids  and  elevation  in  serum 
pro-inflammatory  cytokines  such  as  TNF-α 
and  IL-1β  through  periodontitis  as  a  chronic 
gram (-) infection verified substantial evidences 
supporting this bidirectional relationship.
Hyperlipidemia, arising from a high-fat diet or 
metabolic disorders such as type 2 diabetes, has a 
dysregulatory effect on immune system cells and 
on wound healing and as a result, it increases the 
susceptibility to periodontitis and other infections. 
This condition needs a particular threshold level 
of  circulating  lipids  for  every  individual,  above 
which can lead to this dysregulatory effect within 
the gingival mucosa and elsewhere.5
It  has  been  reported  that  consumption  of  a 
typical high-fat American breakfast (fried eggs, 
bacon,  potatoes)  or  a  defined  saturated-fat-
rich  meal  (i.e.  ice  cream)  leads  to  functional 
abnormalities  in  PMNs.52  A  protective  role  for 
PMNs  in  the  early  response  to  periodontal 
infection is supported by compelling experiments 
in  nature,  wherein  subjects  with  impairments 
of PMN function53 or number54 have more acute 
and  severe  periodontitis.  So,  PMNs  primed  by 
endotoxin  or  other  activating  agents,  including 
dietary  lipids  may  play  a  major  role  in  the 
pathogenesis  of  periodontitis.55  A  possible 
role  of  hyperlipidemia  for  periodontitis  is  also 
obvious  from  several  studies.  Hyperlipidemia 
is  known  to  cause  a  hyperactivity  of  white 
blood cells.56,57 Hyperactivity of white cells, e.g., 
increased  production  of  oxygen  radicals,  have 
been  shown  to  be  frequently  associated  with 
progressive periodontitis in adults.58 In animals 
feeding  a  cholesterol-rich  diet  have  caused  to 
periodontitis.59
In  an  animal  model,  Maglakelidze  et 
al60  have  reported  significant  changes  in 
extracellular  matrix  and  gingival  mucous  cells 
as well as in microcirculatory bed components 
in  hypercholesterolemia.  Hypercholesterolemia 
damages  endotheliocytes,  subendothelial  zone 
and basal membrane permeability. The contact of 
lymphocytes and plasmocytes with the vascular 
wall  confirms  the  trigger  role  of  the  vascular 
factor in damaging of periodontal complex.
There  are  several  studies  which  report 
significant association between plasma lipid levels 
and the severity of the periodontal disease.61-63 
While some authors mentioned that there were 
significant  correlations  between  periodontal 
status and cholesterol levels,64-69 others indicate 
that there were significant associations between 
triglyceride level and periodontal disease.70-72
The studies which trying the effect of periodontal 
therapy on serum lipids and lipoprotein associated 
inflammatuar  mediators73-76  also  suggested 
that  the  treatment  of  periodontal  disease  have 
beneficial  effects  on  lipid  metabolism.  In  one 
study conducted in systemically healthy subjects 
with  periodontitis,  Pussinen  et  al73  stated  that 
periodontitis  is  associated  with  macrophage European Journal of Dentistry
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activation via increased serum LPS concentration. 
Additionally, there was a significant increase in the 
ratio of HDL/LDL after periodontal treatment in this 
study. In another study, Pussinen et al74 reported 
that there were statistically significant decreases in 
CRP and serum amyloid A levels after periodontal 
treatment  in  systemically  healthy  subjects  with 
periodontitis.  That  study  also  suggested  that 
periodontitis  diminishes  the  anti-atherogenic 
potency of HDL and increase the risk for coronary 
heart disease. 
Lösche  et  al75  evaluated  32  patients  with 
moderate  to  severe  periodontitis  before  and  3 
months after local periodontal treatment and they 
reported  that  treatment  of  periodontitis  caused 
a  significant  reduction  in  the  serum  activity  of 
lipoprotein-associated  phospholipase  A2  which  is 
believed to be an independent cardiovascular risk 
factor. In a similar study, 65 subjects presenting 
with  severe  (probing  pocket  depth  greater  than 
6  mm  and  marginal  alveolar  bone  loss  greater 
than  30%),  generalized  (at  least  50%  of  teeth 
affected)  periodontitis  were  assessed  and  the  3 
groups  consisted  of  untreated  control;  standard 
periodontal therapy; and an intensive periodontal 
treatment including standard periodontal treatment 
with  adjunctive  local  delivery  of  minocycline.  In 
that study both standard periodontal therapy and 
intensive periodontal therapy resulted in significant 
reductions  in  serum  CRP  compared  with  the 
untreated  control  and  the  intensive  periodontal 
therapy  group  also  showed  a  decrease  in  total 
and LDL cholesterol after 2 months following the 
periodontal treatment.76
Higher serum levels of total cholesterol, LDL-C 
and  triglycerides  have  been  found  in  subjects 
with periodontal disease,71,77,62 and hyperlipidemic 
patients  have  a  significantly  higher  percentage 
of sites with probing depth greater than 3.5 mm 
than  subjects  with  normal  metabolic  status.78 
The  interrelationship  between  periodontitis  and 
hyperlipidemia provides an example for systemic 
disease  predisposing  to  oral  infection,  and  once 
the  oral  infection  is  established,  it    exacerbates 
systemic disease.
concLusIons 
However, it is unclear whether the association of 
periodontal disease and impaired lipid metabolism 
is a cause-effect interrelationship, namely whether 
periodontitis induces higher serum lipid levels or 
higher serum lipid levels are predisposing factors 
for  periodontitis,  the  association  of  these  two 
phenomenons is widely discussed in the periodontal 
literature.
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